Huntsman CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Huntsman CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024
Revenue	7,518	8,208	7,604	6,797	5,421	7,670	8,023	6,111	6,036	5,683
Cost of revenue	6,000	5,194	5,840	5,415	4,444	6,086	6,477	5,205	5,170	4,932
Gross profit	1,518	1,651	1,764	1,382	977	1,584	1,546	906	866	751
Research and development	137	132	145	137	121	135	125	115	121	120
Selling, general and administrative	772	759	789	786	670	739	711	689	671	670
Operating expenses	855	922	937	913	545	853	874	822	891	882
Operating income	663	729	827	469	432	731	672	84	-25	-131
Other non-operating income	12	8	32	20	31	29	20	-3	21	14
Pre-tax income	474	531	734	391	331	1,246	697	99	-39	-192
Income tax	109	20	45	-38	42	191	186	64	61	26
Income from continuing operations	334	406	608	393	257	996	448	-17	-162	-275
Net income to minority interests	31	105	313	36	32	59	63	52	62	57
Net income	326	636	337	562	1,034	1,045	460	101	-189	-284
EBITDA	981	965	1,082	739	699	1,009	953	362	264	156
EPS, basic	1.38	2.67	1.42	2.46	4.69	4.77	2.29	0.57	-1.10	-1.65
EPS, diluted	1.36	2.61	1.39	2.44	4.66	4.72	2.27	0.57	-1.10	-1.65
Shares, basic (weighted)	236	238	238	229	221	219	201	177	172	173
Shares, diluted (weighted)	240	244	242	231	222	221	203	177	172	173
Dividend per share	0.50	0.50	0.65	0.65	0.65	0.75	0.85	0.95	1.00	0.84

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024
Cash and equivalents	385	470	340	525	1,593	1,041	654	540	340	429
Receivables	1,168	1,256	1,165	940	902	988	813	747	718	670
Inventory	918	1,073	1,000	914	848	1,038	995	867	917	818
Other current assets	232	202	145	155	217	155	190	62	29	46
Total current assets	3,555	5,979	2,958	3,755	3,568	3,928	3,145	2,314	2,125	2,064
Property, plant and equipment	3,034	3,098	2,353	2,383	2,505	2,443	2,377	2,376	2,493	2,486
Lease right-of-use assets				396	445	381	374	366	382	365
Goodwill	121	140	275	276	533	650	641	644	633	630
Intangible assets	43	56	213	197	453	469	425	387	344	308
Other non-current assets	472	497	393	452	548	689	686	611	722	804
Total assets	9,189	10,244	7,953	8,320	8,713	9,392	8,220	7,248	7,114	7,015
Accounts payable	774	946	761	765	842	1,054	907
Accrued liabilities	471	569	497	420	458	713	429	395	416	421
Short-term debt	50	40	96	212	593	12	66	12	325	353
Total current liabilities	1,778	3,265	1,611	2,008	1,979	2,051	1,701	1,172	1,565	1,589
Long-term debt	4,122	2,258	2,224	2,177	1,528	1,538	1,671	1,676	1,510	1,658
Lease liabilities				384	411	346	336	334	348	333
Other non-current liabilities	1,057	1,086	949	898	910	586	422	345	324	322
Total liabilities	7,722	6,873	5,204	5,496	5,040	4,833	4,380	3,770	3,951	4,058
Total debt	4,173	2,298	2,320	2,389	2,121	1,550	1,737	1,688	1,835	2,011
Paid-in capital	3,447	3,889	3,984	4,008	4,048	4,102	4,156	4,202	4,233	4,261
Retained earnings	-325	161	292	690	1,564	2,435	2,705	2,622	2,245	1,810
Treasury stock	-150	-150	-427	-635	-731	-934	-1,937	-2,290	-2,290	-2,290
Other comprehensive income	-1,671	-1,268	-1,316	-1,362	-1,346	-1,203	-1,268	-1,245	-1,200	-1,006
Shareholders' equity	1,287	2,620	2,520	2,687	3,519	4,378	3,624	3,251	2,959	2,750
Minority interests	180	751	229	137	154	181	216	227	204	207
Total equity	1,467	3,371	2,749	2,824	3,673	4,559	3,840	3,478	3,163	2,957
Total liabilities and equity	9,189	10,244	7,953	8,320	8,713	9,392	8,220	7,248	7,114	7,015
Shares outstanding	236	240	233	224	220	214	184	172	172	173

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024
Net income	357	741	650	598	1,066	1,104	523	153	-127	-227
Depreciation and amortization	318	236	255	270	267	278	281	278	289	287
Stock-based compensation	32	36	27	29	26	30	29	28	30	31
Deferred income tax	4	-95	-167	-93	175	-39	89	-10	-15	-32
Change in inventory	177	-88	-80	77	130	-342	-6	125	-77	133
Change in payables	46	127	12	21	11	346	-84	-224	69	-88
Cash from operations	1,088	1,219	1,207	897	253	952	914	209	263	289
Capital expenditures	-318	-234	-251	-274	-237	-326	-272	-230	-184	-173
Acquisitions		-14	-366	0	-650	-245	0	0
Cash from investing	-203	-424	-973	-260	1,463	-524	-279	305	-126	-132
Debt issued	559	24	0	742	0	447	0	0	349	0
Debt repaid	-1,070	-2,058	-68	-676	-21	-990	-12	-11	-13	-328
Stock issued	1	35	17	2	3	10	6	5	0	0
Share buybacks			-277	-208	-96	-200	-1,005	-349	-4	0
Dividends paid	-120	-120	-156	-150	-144	-159	-171	-169	-174	-146
Cash from financing	-723	-519	-424	-450	-655	-977	-994	-620	-326	-76
Exchange rate effect	-6	18	-35	-2
Net change in cash	156	294	-225	185	1,068	-552	-387	-114	-200	89
Free cash flow	770	985	956	623	16	626	642	-21	79	116
Interest paid	205	175	163	111	90	82	66	68	77	86
Income taxes paid	40	25	179	100	316	106	194	97	90	98

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $8.90 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	12.9%	Gross profit / revenue.
Operating margin	-3.3%	Operating income / revenue.
EBITDA margin	1.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-4.4%	Pre-tax income / revenue.
Net margin	-5.8%	Net income / revenue.
FCF margin	2.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.4%	Cash from operations / revenue.
Return on equity (ROE)	-12.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-4.7%	Net income / average total assets.
Return on invested capital (ROIC)	-3.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	2.1%	Research and development expense / revenue.
SG&A / revenue	11.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.1%	Capital expenditures / revenue.
D&A / revenue	5.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-10.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	0.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-13.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-21.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-5.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-40.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-45.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-25.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	9.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-31.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	2.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	46.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-43.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	48.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-16.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-0.5%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	5.2%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-7.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-8.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-4.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-5.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-5.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-4.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.27x	Current assets / current liabilities.
Quick ratio	0.66x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.21x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.77x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	28.8%	Total debt / total assets.
Liabilities / assets	59.3%	Total liabilities / total assets.
Net debt	$1.69B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	16.5x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$460.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	13.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.76B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.80x	Revenue / average total assets.
Fixed asset turnover	2.33x	Revenue / average property, plant and equipment.
Inventory turnover	5.60x	Cost of revenue / average inventory.
Days inventory	65 days	365 x average inventory / cost of revenue.
Receivables turnover	7.40x	Revenue / average receivables.
Days sales outstanding	49 days	365 x average receivables / revenue.
Capex / operating cash flow	56.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.92	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$32.91	Revenue / diluted weighted shares.
FCF per share	$0.78	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.79	Cash from operations / diluted weighted shares.
Book value per share	$15.47	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$10.12	Tangible book value / shares outstanding.
Cash per share	$2.13	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	87.4%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.56B	Share price x shares outstanding.
Enterprise value	$3.25B	Market cap + total debt - cash - short-term investments.
P/S	0.27x	Market cap / revenue.
P/B	0.58x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.89x	Market cap / tangible book value, when positive.
P/FCF	11.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.04x	Market cap / cash from operations, when positive.
EV/Sales	0.57x	Enterprise value / revenue.
EV/EBITDA	31.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	24.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.6%	Free cash flow / market cap.
Earnings yield	-21.3%	Net income / market cap (the inverse of P/E).
Dividend yield	7.6%	Dividends paid over the period / market cap.
Shareholder yield	7.6%	(Dividends paid + share buybacks) / market cap.

What was Huntsman CORP's revenue in fiscal 2024?

Huntsman CORP reported revenue of $5.68B for fiscal 2024, 5.8% lower than the year before.

Was Huntsman CORP profitable in fiscal 2024?

No. It reported a net loss of $284.0M.

How much free cash flow did Huntsman CORP generate in fiscal 2024?

Cash from operations of $289.0M minus capital expenditures of $173.0M left free cash flow of $116.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Huntsman CORP